rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency.

Varga, Lilian; Farkas, Henriette

Varga, Lilian; Farkas, Henriette.

Affiliation

Varga L; 3rd Department of Internal Medicine, Semmelweis University Budapest, H-1125 Kútvölgyi street 4, Budapest, Hungary. lvarga@kut.sote.hu

Expert Rev Clin Immunol ; 7(2): 143-53, 2011 Mar.

Article in En | MEDLINE | ID: mdl-21426252

Subject(s)

Angioedemas, Hereditary/drug therapy; Complement C1 Inhibitor Protein/therapeutic use; Recombinant Proteins/therapeutic use; Angioedemas, Hereditary/immunology; Clinical Trials as Topic; Complement Activating Enzymes/antagonists & inhibitors; Complement C1 Inhibitor Protein/genetics; Complement C1 Inhibitor Protein/metabolism; Complement C1 Inhibitor Protein/pharmacology; Drug Approval; Europe; Humans; Marketing; Recombinant Proteins/genetics; Recombinant Proteins/metabolism; Recombinant Proteins/pharmacology; United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Complement C1 Inhibitor Protein / Angioedemas, Hereditary Limits: Humans Country/Region as subject: America do norte / Europa Language: En Journal: Expert Rev Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2011 Document type: Article Affiliation country: Hungary Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google